You're Invited! Join the Beyfortus Expert Series!

Posted on October 16, 2023

The Beyfortus Expert Series is an ongoing educational series for the healthcare community to learn more about RSV and Beyfortus from leading experts. Beyfortus is a new FDA-approved monoclonal antibody for the prevention of RSV disease in infants.

Calendar of Events:

Each session will air at 5 pm PT | 6 pm MT | 7 pm CT | 8 pm ET on the indicated dates.

• MoA of a Long-Acting Monoclonal Antibody: 11/9 & 11/16
• Pivotal Trials­ – Exploring Efficacy and Safety: 10/19 & 11/9
• Adding a New mAb into Your Formulary: 10/12, 10/26 & 11/15
• Activating Simple Implementation for Hospitals and Clinics: 10/5, 11/1 & 12/5

The sessions will provide an opportunity for expert exchange on Beyfortus clinical data as well as practical considerations for implementation. Each session includes 30-minutes of live discussion with an interactive Q&A. We look forward to your participation!

Click here to learn more about Beyfortus from expert-led discussions and to register.